ERA-EDTA is organizing a series of e-seminars to initiate an open discussion, among the nephrology community, on how the results obtained in the recent trials can be applied to the needs of patients. During these e-seminars, every attendee will learn more about the study’s protocols and results, type of populations studied and parameters followed. There will also be educational elements about the magnitude of the effects in order to provide to the nephrology community a clearer understanding of the benefit and the risk of these, relatively new, classes of drugs.
NEW PHARMACOLOGICAL THERAPIES TO SLOW THE PROGRESSION OF DIABETIC KIDNEY DISEASE
e-seminar #1
Thursday October 15, 2020 at 4 PM BST/5 PM CEST
SGLT2- inhibitors and CKD patients: drugs for everyone?
Panellists
Christoph Wanner, Nephrologist , D
Hiddo J.L. Heerspink, Clinical Pharmacologist, NL
Gert Mayer, Nephrologist, A
Moderated by Kate Stevens, Nephrologist, UK
CLICK HERE TO REGISTER (FOR FREE)
Followed by the
inaugural CKJ Journal Club e-seminar on October 29, 2020 and ERACODA (COVID 19) e-seminar on November 12, 2020.
All e-seminars will start at 4 PM (GMT)/5 PM (CET) and will last approximately 1 hour.
We really hope you will be able to join us! If you miss the live event, most e-seminars will be available on our youtube channel - be sure to
subscribe! The e-seminars from the Working Groups will be available to our members on the Virtual Meeting.
